A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

February 29, 2008

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Azelastine and placebo

One Astelin spray per nostril plus one placebo tablet. In Cross-Over-Design with other arms.

DRUG

Loratadine and Placebo

One placebo spray per nostril plus one Loratadine 10 mg tablet. In Cross-Over-Design with other arms.

DRUG

Cetirizine and Placebo

One placebo spray per nostril plus one 10 mg Cetirizine tablet. In Cross-Over-Design with other arms.

DRUG

Placebo and Placebo (spray and Tablet)

One placebo spray per nostril plus one placebo tablet. In Cross-Over-Design with other arms.

Trial Locations (1)

K7L 2V7

Kingston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Kingston Health Sciences Centre

OTHER

lead

Bayer

INDUSTRY

NCT00561717 - A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis | Biotech Hunter | Biotech Hunter